Skip to main content

Nonprofit · EIN 84-3289802

ALS CURE PROJECT INC

Tax-exempt · PLEASANTON, CA 94566

Financials

$164K$244K2023$860K$219K2024$133K$388K2025
Revenue Expenses · by fiscal year end
Financials of ALS CURE PROJECT INC by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2025990$133,389$388,413-$255,024$484,610$0$484,610
December 31, 2024990$860,387$219,071$641,316$739,634$0$739,634
December 31, 2023990$164,489$244,328-$79,839$98,318$0$98,318
Financial details: 990 for the year ended December 31, 2025

Revenue

Contributions, gifts and grants
$100,116
Program service revenue
$0
Investment income
$8,376
Net income from fundraising events
$24,897
Other revenue
$24,897

Expenses

Grants and similar amounts paid
$382,317
Compensation of officers, directors and key employees
$0
Salaries, compensation and benefits (total)
$0
Professional fundraising fees
$0
Program services (functional)
$382,317
Fundraising (functional)
$1,528

Balance sheet and other

Total assets, start of year
$739,634
Total assets, end of year
$484,610
Total liabilities, end of year
$0
Net assets, end of year
$484,610
Net assets without donor restrictions
$484,610
Gross receipts
$181,213
Employees
0
Volunteers
15
Year formed
2019
State of legal domicile
CA

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2025, highest compensation first.

NameTitleHours / weekCompensation
Mike PiscottyPresident
Trustee or director, Officer
10$0
Stephen PiscottyVIce President
Trustee or director
1$0
Toni EslickSecretary
Trustee or director
6$0
James GilbrethFund Raising Director
Trustee or director
6$0
Barron WesenbergTreasurer
Trustee or director
3$0
Andrew WoodwardIT Communications Director
Trustee or director
3$0
Dave DarbyCorporate Sponsorship Director
Trustee or director
3$0
Jim PooleStrategic Partnership Director
Trustee or director
3$0
990 for the year ended December 31, 2024: 8 people
NameTitleHours / weekCompensation
Mike PiscottyPresident
Trustee or director, Officer
10$0
Stephen PiscottyVIce President
Trustee or director
1$0
Toni EslickSecretary
Trustee or director
6$0
James GilbrethFund Raising Director
Trustee or director
6$0
Barron WesenbergTreasurer
Trustee or director
3$0
Andrew WoodwardIT Communications Director
Trustee or director
3$0
Dave DarbyCorporate Sponsorship Director
Trustee or director
3$0
Jim PooleStrategic Partnership Director
Trustee or director
3$0
990 for the year ended December 31, 2023: 8 people
NameTitleHours / weekCompensation
Mike PiscottyPresident
Trustee or director, Officer
10$0
Stephen PiscottyVIce President
Trustee or director
1$0
Toni EslickSecretary
Trustee or director
6$0
James GilbrethFund Raising Director
Trustee or director
6$0
Barron WesenbergTreasurer
Trustee or director
3$0
Andrew WoodwardIT Communications Director
Trustee or director
3$0
Dave DarbyCorporate Sponsorship Director
Trustee or director
3$0
Jim PooleStrategic Partnership Director
Trustee or director
3$0

Address and contacts

Address (IRS master file)
2808 LONGSPUR WAY, PLEASANTON, CA 94566-5206
In care of
% BARRON WESENBERG
Principal officer (990 for 2025)
Mike Piscotty, 2808 Longspur Way, Pleasanton, CA 94566
Signed the 990
Barron Wesenberg, Treasurer
Phone
(925) 321-5487

California records

California keeps its own records of charities and corporations. Search them by EIN 84-3289802 or by the name ALS CURE PROJECT INC.

Attorney General, Registry of Charities and Fundraisers
Registration status and filed reports (CT-TR-1, RRF-1)

Mission

This year the ALS Cure Project in collabortion with Canadian and US partners continued to fund the multimodal Longitudinal Modeling project along with the Drug Repurposing Project

990 for the year ended December 31, 2025

Program accomplishments

  • 3ML Multimodal Longitudinal Modeling ProjectThis is a multi-nation collaboration project with Canadian and US partners managed by the President of the ALS CURE Project gratis. The University of Alberta was funded to support coordination activities for the MRI, Blood and speech sample and data collection of the Canadian patients involved with the 3ML project. Stanford University received funding to support the development of the 3ML model. Lawrence Livermore National Laboratory was funded through the Livermore Lab Foundation to provide strategic ML oversight and development of key interfaces.
    Expenses $304,317
  • ALS and Parkinsons Drug Repurposing ProjectThis project is a validation of previous work funded at Lawrence Livermore National Laboratory through the Livermore Lab Foundation LLF was funded to validate results using the Optum dataset. The goal of this project is to use ML learning to analyze medical records of ALS patients to search for existing approved drugs off-target which might be useful in extending the life of ALS and PD patients. Funding partners included, LLF, Stanford, ALS Network and the RDM Positive Impact Foundation.
    Expenses $75,000
  • UC Campus ALS MeetingSponsored the poster session reception at this 2 day conference for UC ALS researchers and ALS funding agencies at the University of California Livermore Collaboration Campus.
    Expenses $3,000

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026990 on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
84-3289802
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2019
Accounting year ends
December
Files
Form 990 or 990-EZ
Category (NTEE)
Medical research (H50)
Assets (IRS master file)
$484,610
Income (IRS master file)
$181,213

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2025$133,389$388,413$484,610IRS
990December 2024$860,387$219,071$739,634IRS
990December 2023$164,489$244,328$98,318XML
990December 2022$158,344$245,563$178,157IRS
990December 2021–––IRS
990December 2020–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 84-3289802).

Questions about ALS CURE PROJECT INC

What is the EIN of ALS CURE PROJECT INC?
The employer identification number (EIN) of ALS CURE PROJECT INC is 84-3289802.
Is ALS CURE PROJECT INC tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2019.
Are donations to ALS CURE PROJECT INC tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does ALS CURE PROJECT INC file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of ALS CURE PROJECT INC due?
The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
When did ALS CURE PROJECT INC last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2025.
Who is the principal officer of ALS CURE PROJECT INC?
The 990 for the year ended December 31, 2025 names Mike Piscotty.
Who are the officers and directors of ALS CURE PROJECT INC?
The 990 for the year ended December 31, 2025 lists 8 people; 0 received compensation from the organization.
How much revenue does ALS CURE PROJECT INC have?
On its 990 for the year ended December 31, 2025 it reported revenue of $133,389, expenses of $388,413 and total assets of $484,610 at year end.

Other nonprofits in PLEASANTON

All nonprofits in PLEASANTON · California · Medical research